Journals / Türk Geriatri Dergisi / 2013 / Cilt: 16 - Sayı: 2

Türk populasyonunda periperal visfatindüzeyinin ve visfatin G-948T polimorfizmininAlzheimer hastalığı ile ilişkisi

Association of peripherak visfatin levels and visfatin G-948T gene polymorphism with Alzheimer's disease in a turkish population

Pages
123–128
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Further studies in larger and different populations are needed to fully elaborate the involvement of visfatin gene in AD.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Visfatin is a pleiotropic cytokine implicated in several physiological and patho- physiological processes such as innate immunity, cellular metabolism, longevity, and inflamma- tion.
📊
Key Findings & Data:Altered visfatin levels and visfatin gene polymorphisms have been reported in various human diseases, including type 2 diabetes mellitus, rheumatoid arthritis, obesity, coronary artery disease and stroke.
💡
Conclusion & Impact:Conclusion: Further studies in larger and different populations are needed to fully elaborate the involvement of visfatin gene in AD.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Visfatin is a pleiotropic cytokine implicated in several physiological and patho- physiological processes such as innate immunity, cellular metabolism, longevity, and inflamma- tion. Altered visfatin levels and visfatin gene polymorphisms have been reported in various human diseases, including type 2 diabetes mellitus, rheumatoid arthritis, obesity, coronary artery disease and stroke. Materials and Method: In this study, we investigated whether serum visfatin levels were changed in volunteers with Alzheimer’s disease (AD) (n = 40) or healthy controls (n=40) and whether visfatin gene G-948T polymorphism was associated with the disease. Results: Visfatin levels were not significantly different in AD patients compared with healthy aged control subjects. In this relatively small population, we found a significant, but weak asso- ciation between GT heterozygous genotype at position -948 of visfatin gene and AD. However, there was no association between G-948T polymorphism and visfatin levels, and any demograph- ic, anthropometric or biochemical parameters. Conclusion: Further studies in larger and different populations are needed to fully elaborate the involvement of visfatin gene in AD.

Özet

Girifl: Visfatin, do¤ufltan immünite, hücre metabolizmas›, uzun yaflam ve inflamasyon gibi pek çok fizyolojik ve patofizyolojik olaya kat›lan bir pleiotropik sitokindir. Yükselen visfatin düze- yi ve visfatin gen polimorfizmlerinin tip 2 diyabet mellitus, romatoid artrit, obezite, koroner arter hastal›¤› ve inme gibi çeflitli hastal›klarla iliflkisi daha önce gösterilmifltir. Gereç ve Yöntem: Çal›flmam›zda; Alzheimer Hastal›¤› tan›s› alm›fl gönüllüler (n=40) ve sa¤- l›kl› kontrollerde (n=40), serum visfatin düzeyinin de¤iflimi ve visfatin G-948T gen polimorfizminin AH’na yatk›nl›ktaki rolü araflt›r›lm›flt›r. Bulgular: AH hastalar›n›n serum visfatin düzeylerinde sa¤l›kl› kontrollere k›yasla anlaml› bir fark bulunamam›flt›r. Bu göreceli küçük grupta; visfatin geninin -948 pozisyonundaki GT hetero- zigot genotipi ile AH aras›nda belirgin ancak zay›f bir iliflki bulunmufltur. Ancak yine de G-948T polimorfizmi ile serum visfatin düzeyleri, veya herhangi bir demografik, antropometrik ya da bi- yokimyasal veri aras›nda bir iliflki bulunamam›flt›r. Sonuç: Visfatinin AH ile iliflkisini kesin olarak belirleyebilmek için daha genifl ve farkl› popu- lasyonlarda yap›lacak ileri araflt›rmalara ihtiyaç duyulmaktad›r.

🔖

Cite This Article

GENÇ, Ş., GENÇ, K. K., VURGUN, U., TÜFEKÇİ, K. U., KESKİNOĞLU, P., YENER, G., ŞAHİN, Ö. (2022). Türk populasyonunda periperal visfatindüzeyinin ve visfatin G-948T polimorfizmininAlzheimer hastalığı ile ilişkisi. Türk Geriatri Dergisi, Cilt: 16 - Sayı: 2, 123–128. https://ajindex.com/articles/623964

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Ballard C, Gauthier S, Corbett A, et.al. Alzheimer’s disease. Lancet 2011;377(9770):1019-31. (PMID:21371747)
  2. Bertram L, Lill CM, Tanzi RE. The genetics of Alzheimer dis- ease: back to the future. Neuron 2010 Oct 21;68(2):270-81. (PMID:20955934)
  3. Perry VH. Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol 2010;120(3):277-86. (PMID:20644946)
  4. Di Bona D, Candore G, Franceschi C, et al. Systematic review by meta-analyses on the possible role of TNF-alpha polymor hisms in association with Alzheimer’s disease. Brain Res Rev 2009;61(2):60-8. (PMID:19445962)
  5. Sims-Robinson C, Kim B, Rosko A, et al. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol 2010;6(10):551-9. (PMID:20842183)
  6. Luk T, Malam Z, Marshall JC. Pre-B cell colony-enhancing fac- tor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 2008;83(4):804-16. (PMID:18252866)
  7. Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006 Jan;91(1):295-9. (PMID:16234302)
  8. Otero M, Lago R, Gomez R, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65(9):1198-201. (PMID:16414972)
  9. Moschen AR, Kaser A, Enrich B, et al. Visfatin, an adipocy- tokine with proinflammatory and immunomodulating proper- ties. J Immunol 2007 1;178(3):1748-58. (PMID:17237424)
  10. Johansson LM, Johansson LE, Ridderstråle M. The visfatin (PBEF1) G-948T gene polymorphism is associated with increased high-density lipoprotein cholesterol in obese subjects. Metabolism 2008;57(11):1558-62. (PMID:18940394)
  11. Zhang YY, Gottardo L, Thompson R, et al. A visfatin promot- er polymorphism is associated with low-grade inflammation and type 2 diabetes. Obesity (Silver Spring) 2006;14(12):2119- 26. (PMID:17189536)
  12. McKhann GM, Knopman DS, Chertkow H, et al. The diagno- sis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 2011;7(3):263-9. (PMID:21514250)
  13. Sonoli SS, Shivprasad S, Prasad CV, et al. Visfatin-a review. Eur Rev Med Pharmacol Sci 2011;15(1):9-14. (PMID:21381495)
  14. Lu LF, Yang SS, Wang CP, et al. Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentratio